|
|
Thomson Financial Business Description:
| The Group's principal activities are the research, development, production, marketing and sale of pharmaceuticals for treating diseases of the central nervous system (CNS). The Group specialises in psychiatry and neurology, focusing exclusively on treatments of psychosis, depression, anxiety, schizophrenia, Parkinson's disease, Alzheimer's disease and dementia. The product group includes Cipralex, Lexapro, Azilect and other pharmaceuticals. The Group operates globally in 54 countries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on H. Lundbeck A/S
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
